Inventor · disambiguated record
Peter Greasley
Also filed as: GREASLEY PETER
4 granted patents·10 pending applications·13 citations·filing 2002–2024
71Inventor score
Files withASTRAZENECA AB14
Top patents by PatentIndex Score
14 records- 0191US11730735B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2021·Granted Aug 22, 2023·5 cites·21 claims
- 0289US12121517B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2023·Granted Oct 22, 2024·2 cites·21 claims
- 0383US12409174B2Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseasesASTRAZENECA AB·Filed 2024·Granted Sep 9, 2025·0 cites·35 claims
- 0463US7342019B25, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonistsASTRAZENECA AB·Filed 2002·Granted Mar 11, 2008·6 cites·13 claims
- 0558US2024307383A1Combination of zibotentan and dapagliflozin for the treatment of proteinuria chronic kidney diseaseASTRAZENECA AB·Filed 2024·Application pending·0 cites
- 0654US2025316377A1Predicting albuminuria using machine learningASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0754US2024058331A1Combination therapies for treatment of cirrhosis with portal hypertensionASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0849US2007117138A1Splice variant cannabinoid receptor (cb1b)ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0947US2025253057A1Predicting disease progression in portal hypertension using machine learningASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1044US2023165856A1Dapagliflozin and ambrisentan for the prevention and treatment of covid-19ASTRAZENECA AB·Filed 2021·Application pending·0 cites
- 1140US2005239133A1Methods to identify true antagonists and inverse agonists of the cannabinoid receptorASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 1240US2006194260A1Screening assays for cannabinoid-ligand-type modulators of gpr55ASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 1338US2006122229A14,5-diarylthiazole derivatives as cb-1 ligandsASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 1436US2006122230A11,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulatorsASTRAZENECA AB·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Greasley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →